EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 107 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $136,000 | +615.8% | 17,069 | +700.2% | 0.00% | – |
| Q2 2023 | $19,000 | +46.2% | 2,133 | -52.2% | 0.00% | – |
| Q1 2023 | $13,000 | -65.8% | 4,460 | -59.5% | 0.00% | – |
| Q4 2022 | $38,000 | -29.6% | 11,015 | +63.6% | 0.00% | – |
| Q3 2022 | $54,000 | +5.9% | 6,732 | +2.8% | 0.00% | – |
| Q2 2022 | $51,000 | -47.4% | 6,551 | -17.4% | 0.00% | – |
| Q1 2022 | $97,000 | +31.1% | 7,934 | +31.9% | 0.00% | – |
| Q4 2021 | $74,000 | +94.7% | 6,016 | +64.1% | 0.00% | – |
| Q3 2021 | $38,000 | +90.0% | 3,666 | +67.0% | 0.00% | – |
| Q2 2021 | $20,000 | +122.2% | 2,195 | +173.0% | 0.00% | – |
| Q1 2021 | $9,000 | +28.6% | 804 | -24.9% | 0.00% | – |
| Q4 2020 | $7,000 | – | 1,071 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,490,921 | $27,892,459 | 24.59% |
| ACUTA CAPITAL PARTNERS, LLC | 300,128 | $2,398,023 | 1.61% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,492,147 | $27,902,255 | 1.51% |
| Cormorant Asset Management, LP | 3,200,000 | $25,568,000 | 1.49% |
| Samsara BioCapital, LLC | 432,000 | $3,451,680 | 1.06% |
| Ghost Tree Capital, LLC | 325,000 | $2,596,750 | 0.85% |
| RA Capital Management | 3,370,506 | $26,930,343 | 0.53% |
| Ikarian Capital, LLC | 4,487 | $3,585,113 | 0.43% |
| Affinity Asset Advisors, LLC | 155,000 | $1,238,450 | 0.35% |
| SECTORAL ASSET MANAGEMENT INC | 176,080 | $1,406,879 | 0.27% |